TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory - BRFSS Asthma Call-back Survey, United States, 2009
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Arizona | 113 | 34.6 | 7.4 | (20.1 – 49.1) | 118 | 35.2 | 7.3 | (20.9 – 49.5) |
| California | 517 | 35.2 | 3.3 | (28.7 – 41.7) | 549 | 32.3 | 3.2 | (26.0 – 38.6) |
| Connecticut | 235 | 30.5 | 4.2 | (22.3 – 38.7) | 257 | 29.0 | 4.0 | (21.2 – 36.8) |
| District of Columbia | 134 | 25.9 | 4.6 | (16.9 – 34.9) | 151 | 24.2 | 4.2 | (16.0 – 32.4) |
| Florida | 416 | 26.7 | 3.5 | (19.8 – 33.6) | 454 | 23.2 | 3.4 | (16.5 – 29.9) |
| Georgia | 192 | 30.5 | 4.9 | (20.9 – 40.1) | 198 | 26.7 | 4.7 | (17.5 – 35.9) |
| Hawaii | 278 | 40.9 | 4.9 | (31.3 – 50.5) | 275 | 42.7 | 4.9 | (33.1 – 52.3) |
| Illinois | 185 | 39.6 | 5.1 | (29.6 – 49.6) | 204 | 36.3 | 4.8 | (26.9 – 45.7) |
| Indiana | 391 | 29.6 | 3.5 | (22.7 – 36.5) | 426 | 27.6 | 3.3 | (21.1 – 34.1) |
| Iowa | 233 | 30.6 | 4.3 | (22.2 – 39.0) | 247 | 28.3 | 4.1 | (20.3 – 36.3) |
| Kansas | 828 | 32.6 | 2.5 | (27.7 – 37.5) | 885 | 32.4 | 2.5 | (27.5 – 37.3) |
| Louisiana | 196 | 32.9 | 5.5 | (22.1 – 43.7) | 218 | 30.0 | 4.9 | (20.4 – 39.6) |
| Maine | 235 | 27.9 | 3.7 | (20.6 – 35.2) | 254 | 26.9 | 3.4 | (20.2 – 33.6) |
| Maryland | 267 | 28.6 | 3.9 | (21.0 – 36.2) | 289 | 27.3 | 3.6 | (20.2 – 34.4) |
| Massachusetts | 225 | 44.0 | 5.7 | (32.8 – 55.2) | 252 | 38.7 | 5.1 | (28.7 – 48.7) |
| Michigan | 471 | 38.4 | 3.3 | (31.9 – 44.9) | 531 | 33.9 | 2.9 | (28.2 – 39.6) |
| Montana | 307 | 33.1 | 4.3 | (24.7 – 41.5) | 318 | 34.7 | 4.2 | (26.5 – 42.9) |
| Nebraska | 540 | 32.8 | 3.8 | (25.4 – 40.2) | 548 | 33.8 | 3.8 | (26.4 – 41.2) |
| Nevada | 131 | 36.6 | 9.5 | (18.0 – 55.2) | 139 | 34.0 | 9.0 | (16.4 – 51.6) |
| New Hampshire | 259 | 44.7 | 4.8 | (35.3 – 54.1) | 283 | 39.8 | 4.5 | (31.0 – 48.6) |
| New Jersey | 360 | 28.0 | 3.6 | (20.9 – 35.1) | 392 | 25.5 | 3.2 | (19.2 – 31.8) |
| New Mexico | 205 | 44.1 | 5.0 | (34.3 – 53.9) | 226 | 39.4 | 4.8 | (30.0 – 48.8) |
| New York | 326 | 40.9 | 5.0 | (31.1 – 50.7) | 357 | 38.1 | 4.8 | (28.7 – 47.5) |
| North Dakota | 190 | 37.0 | 4.9 | (27.4 – 46.6) | 200 | 37.7 | 4.7 | (28.5 – 46.9) |
| Ohio | 276 | 23.8 | 3.5 | (16.9 – 30.7) | 299 | 22.8 | 3.3 | (16.3 – 29.3) |
| Oklahoma | 283 | 28.1 | 3.8 | (20.7 – 35.5) | 293 | 27.3 | 3.7 | (20.0 – 34.6) |
| Oregon | 149 | 42.5 | 5.9 | (30.9 – 54.1) | 164 | 38.6 | 5.4 | (28.0 – 49.2) |
| Rhode Island | 302 | 32.3 | 3.9 | (24.7 – 39.9) | 326 | 29.2 | 3.6 | (22.1 – 36.3) |
| Texas | 472 | 31.5 | 3.8 | (24.1 – 38.9) | 505 | 26.8 | 3.4 | (20.1 – 33.5) |
| Utah | 433 | 27.9 | 2.8 | (22.4 – 33.4) | 481 | 25.6 | 2.6 | (20.5 – 30.7) |
| Vermont | 360 | 37.2 | 4.5 | (28.4 – 46.0) | 385 | 36.4 | 4.3 | (28.0 – 44.8) |
| Virginia | 183 | 20.7 | 4.1 | (12.7 – 28.7) | 189 | 20.0 | 4.0 | (12.2 – 27.8) |
| Washington | 491 | 38.6 | 3.9 | (31.0 – 46.2) | 533 | 35.4 | 3.6 | (28.3 – 42.5) |
| West Virginia | 248 | 35.0 | 4.5 | (26.2 – 43.8) | 257 | 34.6 | 4.4 | (26.0 – 43.2) |
| Wisconsin | 223 | 48.8 | 5.9 | (37.2 – 60.4) | 235 | 46.5 | 5.7 | (35.3 – 57.7) |
| Puerto Rico | 165 | 23.2 | 4.7 | (14.0 – 32.4) | 245 | 17.6 | 3.4 | (10.9 – 24.3) |
| 36 state total | 10,819 | 34.0 | 1.0 | (32.0 – 36.0) | 11,683 | 31.1 | 1.0 | (29.1 – 33.1) |
| Median | 32.9 | 32.4 | ||||||
| Range | 20.7-48.8 | 17.6-46.5 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
Page last reviewed: August 1, 2014